Early Cancer Detection in Dogs: Unveiling the Nu.Q® Vet Cancer Test

In our latest webinar, we dive into the revolutionary Nu.Q® Vet Cancer Test, a cutting-edge tool designed for the early screening of canine cancer in healthy, asymptomatic dogs. Led by Dr. Heather Wilson-Robles, Chief Medical Officer for Volition Veterinary, this webinar explores the scientific principles, real-world applications, and impactful case studies surrounding this groundbreaking diagnostic advancement.

Join us for an enlightening session as we unravel the Nu.Q® Vet Cancer Test, delving into its biomarker technology and the methodologies that enable accurate and early cancer detection. Dr. Wilson-Robles, the principal researcher behind the test, shares valuable insights into its developmental journey and future implications in canine health.

Learning Objectives:

1. Expert Insights: Gain expert knowledge from Dr. Heather Wilson-Robles, understanding the developmental journey and future implications of the Nu.Q® Vet Cancer Test in canine health.

2. Impact on Treatment Planning: Explore how early cancer detection through the test influences treatment decisions and prognosis for dogs.

3. Real-World Applications: Analyze practical applications through case studies, gaining insights into the test's effectiveness in various clinical scenarios.

4. Scientific Principles: Delve into the biomarker technology underpinning the Nu.Q® Vet Cancer Test, learning about the scientific methodologies enabling its accurate detection.

5. Role in Canine Cancer Detection: Understand the test's role as a significant advancement in early cancer detection in healthy dogs, emphasizing its potential impact on veterinary medicine.

Speaker: Dr. Heather Wilson-Robles

Dr. Heather Wilson-Robles, an accomplished figure in veterinary oncology, guides us through the Nu.Q® Vet Cancer Test. With a wealth of experience and research achievements, Dr. Wilson-Robles offers a unique perspective on this innovative screening tool, its applications, and its role in advancing cancer diagnostics.

Key Points:

- Webinar filled with case studies and backed by comprehensive statistics.

- Emphasizes the importance of cancer screening, optimal timing, and integration into routine checkups.

- In-depth explanation of how Nu.Q® Vet Cancer Test quantifies circulating nucleosome levels in blood, boasting a 97% specificity.

- Availability and companies offering the test in the USA, Canada, Australia, UK, Italy, and Portugal.

- Detailed interpretation of test results and recommended actions.

Testimonials:

- "Many thanks for the excellent webinar."

- "Very well documented and very useful."

- "Thank you for arranging these webinars! They are super!"

- "Excellent webinar - many thanks!"

- "Well-documented and with many useful pieces of information."

Sponsored by Volition Veterinary, the webinar is free to watch. Don't miss out on the insights that could revolutionize cancer detection in our canine companions.

Detect | Treat | Monitor: Early Detection Journey with The Nu.Q® Vet Cancer Test

Watch Here